Ziyad Al-Aly
#155,668
Most Influential Person Now
American clinical epidemiologist
Ziyad Al-Aly's AcademicInfluence.com Rankings
Ziyad Al-Alymedical Degrees
Medical
#3130
World Rank
#3585
Historical Rank
Epidemiology
#628
World Rank
#654
Historical Rank
Ziyad Al-Alyphilosophy Degrees
Philosophy
#9869
World Rank
#13489
Historical Rank
Logic
#6822
World Rank
#8372
Historical Rank
Download Badge
Medical Philosophy
Why Is Ziyad Al-Aly Influential?
(Suggest an Edit or Addition)According to Wikipedia, Ziyad Al-Aly is an American physician and clinical epidemiologist who is currently Director of the Clinical Epidemiology Center and Chief of the Research and Development at the Veterans Affairs St. Louis Health Care System. He is also a clinical epidemiologist at Washington University in St. Louis. He has led multiple studies on long COVID and its sequelae.
Ziyad Al-Aly's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (2018) (5789)
- Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 (2017) (5399)
- Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 (2015) (4436)
- Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 (2016) (4388)
- Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015 (2016) (4293)
- Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 (2020) (4169)
- Health Effects of Overweight and Obesity in 195 Countries over 25 Years. (2017) (4063)
- Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016 (2017) (3330)
- Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017 (2018) (3308)
- Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (2018) (2239)
- Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 (2020) (2016)
- Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 (2017) (1869)
- Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (2020) (1788)
- Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 (2016) (1580)
- Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (2018) (1515)
- Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 (2018) (1481)
- Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 (2017) (1477)
- Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015 (2017) (1090)
- Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017 (2019) (1041)
- The State of US Health, 1990-2016: Burden of Diseases, Injuries, and Risk Factors Among US States (2018) (866)
- High-dimensional characterization of post-acute sequelae of COVID-19 (2021) (658)
- Global, regional, and national levels of maternal mortality, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 (2016) (623)
- Long-term cardiovascular outcomes of COVID-19 (2022) (570)
- Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016 (2018) (561)
- Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2015: the Global Burden of Disease Study 2015 (2016) (549)
- Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017 (2018) (538)
- Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019 (2020) (522)
- Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016 (2017) (495)
- Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016. (2018) (462)
- Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015: a novel analysis from the Global Burden of Disease Study 2015 (2017) (452)
- Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015 (2016) (394)
- Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019 (2021) (331)
- Aortic Msx2-Wnt Calcification Cascade Is Regulated by TNF-&agr;–Dependent Signals in Diabetic Ldlr−/− Mice (2007) (295)
- Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016 (2017) (280)
- Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 (2020) (279)
- Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019 (2021) (259)
- Proton Pump Inhibitors and Risk of Incident CKD and Progression to ESRD. (2016) (238)
- Long COVID after breakthrough SARS-CoV-2 infection (2022) (219)
- The 2016 global and national burden of diabetes mellitus attributable to PM2·5 air pollution. (2018) (202)
- Risk of death among users of Proton Pump Inhibitors: a longitudinal observational cohort study of United States veterans (2017) (192)
- Particulate Matter Air Pollution and the Risk of Incident CKD and Progression to ESRD. (2017) (182)
- Global Cardiovascular and Renal Outcomes of Reduced GFR. (2017) (167)
- Rate of kidney function decline associates with mortality. (2010) (165)
- Changes in serum 25-hydroxyvitamin D and plasma intact PTH levels following treatment with ergocalciferol in patients with CKD. (2007) (163)
- Burden of Cause-Specific Mortality Associated With PM2.5 Air Pollution in the United States (2019) (161)
- Early nephrologist involvement in hospital-acquired acute kidney injury: a pilot study. (2011) (154)
- High Density Lipoprotein Cholesterol and the Risk of All-Cause Mortality among U.S. Veterans. (2016) (141)
- Estimates of all cause mortality and cause specific mortality associated with proton pump inhibitors among US veterans: cohort study (2019) (141)
- Acute Kidney Injury in a National Cohort of Hospitalized US Veterans with COVID-19. (2020) (139)
- Risks and burdens of incident diabetes in long COVID: a cohort study (2022) (134)
- Long-term kidney outcomes among users of proton pump inhibitors without intervening acute kidney injury. (2017) (123)
- Burdens of post-acute sequelae of COVID-19 by severity of acute infection, demographics and health status (2021) (122)
- Risks of mental health outcomes in people with covid-19: cohort study (2022) (118)
- Kidney Outcomes in Long COVID (2021) (113)
- Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019 (2021) (108)
- The natural history of renal function following orthotopic heart transplant (2005) (106)
- Associations of ambient coarse particulate matter, nitrogen dioxide, and carbon monoxide with the risk of kidney disease: a cohort study. (2017) (104)
- Comparative evaluation of clinical manifestations and risk of death in patients admitted to hospital with covid-19 and seasonal influenza: cohort study (2020) (103)
- Low levels of high-density lipoprotein cholesterol increase the risk of incident kidney disease and its progression. (2016) (103)
- Higher blood urea nitrogen is associated with increased risk of incident diabetes mellitus. (2017) (100)
- Changes in the US Burden of Chronic Kidney Disease From 2002 to 2016 (2018) (100)
- Achieving K/DOQI Laboratory Target Values for Bone and Mineral Metabolism: An Uphill Battle (2004) (81)
- Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021. (2022) (78)
- Erratum: Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1736–1788)(S0140673618322037)(10.1016/S0140-6736(18)32203-7)) (2018) (75)
- Arterial calcification: a tumor necrosis factor-alpha mediated vascular Wnt-opathy. (2008) (74)
- The global distribution of lymphatic filariasis, 2000–18: a geospatial analysis (2020) (70)
- Greater variability in kidney function is associated with an increased risk of death. (2012) (69)
- Acute and postacute sequelae associated with SARS-CoV-2 reinfection (2022) (63)
- Tamm-Horsfall protein-deficient thick ascending limbs promote injury to neighboring S3 segments in an MIP-2-dependent mechanism. (2011) (61)
- Tumor necrosis factor-α blockade, cardiovascular outcomes, and survival in rheumatoid arthritis. (2011) (59)
- Sustainable Development Goals relevant to kidney health: an update on progress (2020) (57)
- Proton Pump Inhibitors and the Kidney: Implications of Current Evidence for Clinical Practice and When and How to Deprescribe. (2020) (55)
- Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019 (2022) (54)
- Long-term neurologic outcomes of COVID-19 (2022) (54)
- Mental health disorders and the risk of AIDS-defining illness and death in HIV-infected veterans (2012) (53)
- Mapping geographical inequalities in access to drinking water and sanitation facilities in low-income and middle-income countries, 2000–17 (2020) (52)
- Association between Monocyte Count and Risk of Incident CKD and Progression to ESRD. (2017) (51)
- Rate of Kidney Function Decline and Risk of Hospitalizations in Stage 3A CKD. (2015) (51)
- Estimates of the 2016 global burden of kidney disease attributable to ambient fine particulate matter air pollution (2019) (50)
- Medial vascular calcification in diabetes mellitus and chronic kidney disease: the role of inflammation. (2007) (49)
- Burden of obesity in the Eastern Mediterranean Region: findings from the Global Burden of Disease 2015 study (2017) (48)
- Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017 (2020) (47)
- Comparative Effectiveness of SGLT2 Inhibitors, GLP-1 Receptor Agonists, DPP-4 Inhibitors, and Sulfonylureas on Risk of Kidney Outcomes: Emulation of a Target Trial Using Health Care Databases (2020) (47)
- Ambient fine particulate matter air pollution and the risk of hospitalization among COVID-19 positive individuals: Cohort study (2021) (44)
- Estimated GFR Trajectories of People Entering CKD Stage 4 and Subsequent Kidney Disease Outcomes and Mortality. (2016) (43)
- Global, regional, and national mortality among young people aged 10–24 years, 1950–2019: a systematic analysis for the Global Burden of Disease Study 2019 (2021) (42)
- Routine Replacement of Tunneled, Cuffed, Hemodialysis Catheters Eliminates Paraspinal/Vertebral Infections in Patients with Catheter-Associated Bacteremia (2003) (41)
- Extracorporeal Management of Valproic Acid Toxicity: A Case Report and Review of the Literature (2005) (41)
- Phosphate, oxidative stress, and nuclear factor-κB activation in vascular calcification. (2011) (40)
- Geographic Variation and US County Characteristics Associated With Rapid Kidney Function Decline (2016) (39)
- Global, regional, and national burden of diseases and injuries for adults 70 years and older: systematic analysis for the Global Burden of Disease 2019 Study (2022) (37)
- Thrombotic thrombocytopenic purpura in a patient treated with imatinib mesylate: true association or mere coincidence? (2005) (37)
- Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018 (2021) (32)
- Temporal Trends in Incidence Rates of Lower Extremity Amputation and Associated Risk Factors Among Patients Using Veterans Health Administration Services From 2008 to 2018 (2021) (32)
- C4d peritubular capillary staining in chronic allograft nephropathy and transplant glomerulopathy: an uncommon finding (2005) (31)
- Mapping disparities in education across low- and middle-income countries (2019) (30)
- The global and national burden of chronic kidney disease attributable to ambient fine particulate matter air pollution: a modelling study (2020) (30)
- Diabetes mortality and trends before 25 years of age: an analysis of the Global Burden of Disease Study 2019 (2022) (29)
- Vascular biology in uremia: insights into novel mechanisms of vascular injury. (2004) (29)
- Vitamin D as a novel nontraditional risk factor for mortality in hemodialysis patients: the need for randomized trials. (2007) (27)
- Nirmatrelvir and the Risk of Post-Acute Sequelae of COVID-19 (2022) (27)
- Erratum: Global, regional, and national levels of maternal mortality, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 (The Lancet (2016) 388(10053) (1775–1812)(S0140673616314702)(10.1016/S0140-6736(16)31470-2)) (2017) (27)
- Subnational mapping of HIV incidence and mortality among individuals aged 15–49 years in sub-Saharan Africa, 2000–18: a modelling study (2021) (26)
- Diabetes mellitus and chronic kidney disease in the Eastern Mediterranean Region: findings from the Global Burden of Disease 2015 study (2017) (25)
- A global systematic analysis of the occurrence, severity, and recovery pattern of long COVID in 2020 and 2021 (2022) (24)
- Comparative Effectiveness of Sodium-Glucose Cotransporter 2 Inhibitors vs Sulfonylureas in Patients With Type 2 Diabetes (2021) (24)
- Vascular calcification in uremia: what is new and where are we going? (2008) (24)
- Renal Function Trajectories in Patients with Prior Improved eGFR Slopes and Risk of Death (2016) (24)
- Measuring the availability of human resources for health and its relationship to universal health coverage for 204 countries and territories from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019 (2022) (23)
- Serum phosphorus levels and risk of incident dementia (2017) (23)
- Prediction of renal end points in chronic kidney disease. (2013) (23)
- Comparative Effectiveness of the Sodium–Glucose Cotransporter 2 Inhibitor Empagliflozin Versus Other Antihyperglycemics on Risk of Major Adverse Kidney Events (2020) (23)
- Temporal trends of COVID-19 mortality and hospitalisation rates: an observational cohort study from the US Department of Veterans Affairs (2021) (21)
- Pasteurella multocida peritoneal dialysis-associated peritonitis: a report of two cases and review of the literature. (2005) (20)
- Spatial, temporal, and demographic patterns in prevalence of chewing tobacco use in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019 (2021) (20)
- Mapping geographical inequalities in oral rehydration therapy coverage in low-income and middle-income countries, 2000–17 (2020) (20)
- Air Pollution and Kidney Disease. (2020) (19)
- Ambient Fine Particulate Matter Air Pollution and Risk of Weight Gain and Obesity in United States Veterans: An Observational Cohort Study (2021) (18)
- Erratum:Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016 (The Lancet (2017) 390(10100) (1423–1459) (S0 (2017) (16)
- Renal allograft biopsies in the era of C4d staining: the need for change in the Banff classification system (2008) (16)
- Difficulties in Achieving the K/DOQI Practice Guidelines for Bone and Mineral Metabolism (2005) (15)
- Clinical Implications of Estimated Glomerular Filtration Rate Dip Following Sodium‐Glucose Cotransporter‐2 Inhibitor Initiation on Cardiovascular and Kidney Outcomes (2021) (14)
- Diabetes Minimally Mediated the Association Between PM2.5 Air Pollution and Kidney Outcomes (2020) (13)
- The association of proton pump inhibitors and chronic kidney disease: cause or confounding? (2018) (13)
- Blood urea nitrogen and risk of insulin use among people with diabetes (2018) (13)
- Estimates, trends, and drivers of the global burden of type 2 diabetes attributable to PM2·5 air pollution, 1990–2019: an analysis of data from the Global Burden of Disease Study 2019 (2022) (13)
- Outcomes of SARS-CoV-2 Reinfection (2022) (12)
- County-Level Contextual Characteristics and Disparities in Life Expectancy. (2021) (12)
- Metabolic acidosis and vascular calcification: using blueprints from bone to map a new venue for vascular research. (2008) (11)
- Burden of diabetes and hyperglycaemia in adults in the Americas, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 (2022) (11)
- The new role of calcimimetics as vasculotropic agents. (2009) (11)
- Risks and burdens of incident dyslipidaemia in long COVID: a cohort study (2023) (10)
- Long Covid after Breakthrough COVID-19: the post-acute sequelae of breakthrough COVID-19 (2021) (9)
- Preliminary experience with mycophenolate mofetil for preservation of renal function in cardiac transplant patients with documented cyclosporine nephrotoxicity (2006) (9)
- Rate of Change in Kidney Function and the Risk of Death: The Case for Incorporating the Rate of Kidney Function Decline into the CKD Staging System (2011) (8)
- Acute kidney injury after cardiac surgery: is minocycline protective? (2015) (8)
- Association of Treatment With Nirmatrelvir and the Risk of Post-COVID-19 Condition. (2023) (7)
- Long COVID: long-term health outcomes and implications for policy and research (2022) (7)
- Fine particulate matter components and interstitial lung disease in rheumatoid arthritis (2021) (7)
- Long-term gastrointestinal outcomes of COVID-19 (2023) (7)
- The Road Ahead for Research on Air Pollution and Kidney Disease. (2021) (6)
- Diabetes after SARS-CoV-2 infection (2022) (6)
- Mapping development and health effects of cooking with solid fuels in low-income and middle-income countries, 2000–18: a geospatial modelling study (2022) (5)
- Molnupiravir and risk of hospital admission or death in adults with covid-19: emulation of a randomized target trial using electronic health records (2023) (5)
- Predicting the environmental suitability for onchocerciasis in Africa as an aid to elimination planning (2021) (5)
- Mental health in people with covid-19 (2022) (5)
- A Deep Learning Approach for the Estimation of Glomerular Filtration Rate (2022) (2)
- Air Pollution and Acute Kidney Injury in the U.S. Medicare Population: A Longitudinal Cohort Study (2023) (2)
- Nirmatrelvir and risk of hospital admission or death in adults with covid-19: emulation of a randomized target trial using electronic health records (2023) (2)
- Association of Ambient Fine Particulate Matter Air Pollution With Kidney Transplant Outcomes (2021) (2)
- High density lipoprotein cholesterol and risk of death. (2016) (2)
- Publisher Correction: Sustainable Development Goals relevant to kidney health: an update on progress (2021) (2)
- Monocyte count modifies the association between chronic kidney disease and risk of death . (2018) (2)
- Reviewers for Mayo Clinic Proceedings (2016). (2018) (2)
- JAMA Network Open Peer Reviewers in 2021. (2022) (1)
- JAMA Peer Reviewers in 2021. (2022) (1)
- Evaluation of serum anion gap in patients with HIV. (2007) (1)
- One-year Risks and Burdens of Incident Cardiovascular Disease in COVID-19: Cardiovascular Manifestations of Long COVID (2021) (1)
- Burdens of Post-acute Sequelae of COVID-19 by Age, Race, Sex, and Health Status (2021) (1)
- Biomarkers of CKD in Children. (2020) (1)
- The overlapping burden of the three leading causes of disability and death in sub-Saharan African children (2022) (1)
- Vitamin D levels and early mortality among incident hemodialysis patients. Commentary (2007) (1)
- Risk of Death in Patients Hospitalized for COVID-19 vs Seasonal Influenza in Fall-Winter 2022-2023. (2023) (1)
- Molnupiravir and risk of post-acute sequelae of covid-19: cohort study (2023) (1)
- Impact of COVID-19 on the sustainable development agenda and global kidney health. (2023) (0)
- 18 INFLIXIMAB REDUCES AORTIC BMP2-MSX2-WNT SIGNALS AND VASCULAR CALCIFICATION IN DIABETIC LDLR−/P− MICE. (2007) (0)
- Worldwide cardiovascular and ESRD outcomes attributable to reduced GFR Running Title: Reduced GFR-attributed health loss (2018) (0)
- JASN315Editorial 893..897 (2020) (0)
- Comparative Effectiveness of Sodium-Glucose Cotransporter 2 Inhibitors vs Sulfonylureas in Patients With Type 2 Diabetes-Reply. (2021) (0)
- Acknowledgement to Reviewers (2012) (0)
- We Must all Join the Effort to Dismantle Environmental Racism. (2021) (0)
- Acknowledgement to the Reviewers (2011) (0)
- cholesterol increase the risk of incident Low levels of high-density lipoprotein kidney disease and its progression (2016) (0)
- A big data approach to examine the association of high density lipoprotein cholesterol and mortality: lessons for future investigations. (2017) (0)
- Thanks to Reviewers—2020 (2020) (0)
- Reviewer Thank You (2019) (0)
- to reduced GFR (2017) (0)
- Estimates of burden of death and cause specific mortality associated with proton pump inhibitors among US veterans : a cohort study (2019) (0)
- Author Correction: Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017 (2020) (0)
- Review for "Effectiveness and safety of empagliflozin in routine care patients: results from the EMPagliflozin compaRative effectIveness and SafEty ( EMPRISE ) study" (2021) (0)
- Review for "The Present & Future Scope of RWE Research in Diabetes: What Questions Can and Can’t Be Answered and What Might be Possible in the Future?" (2019) (0)
- Erratum: Correction to Lancet HIV ((2016) 3 (e361–87)(S235230181630087X)(10.1016/S2352-3018(16)30087-X) (2016) (0)
- Acknowledgement to the Reviewers (2018) (0)
- Review for "Lower risk of death and cardiovascular events in patients with diabetes initiating GLP ‐1 receptor agonists or SGLT ‐2 inhibitors: a real‐world study on two Italian cohorts" (2021) (0)
- Review for "Enrolment criteria for diabetes cardiovascular outcome trials do not inform on generalizability to clinical practice. The case of GLP‐1 receptor agonists" (2019) (0)
This paper list is powered by the following services:
Other Resources About Ziyad Al-Aly
What Schools Are Affiliated With Ziyad Al-Aly?
Ziyad Al-Aly is affiliated with the following schools:
